Aimin Jiang
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 17
- Ferroptosis and cancer prognosis 15
-
- Renal and related cancers 8
- Epigenetics and DNA Methylation 8
- Co-authors
- Peng Luo (31 shared papers)Anqi Lin (24 shared papers)Jian Zhang (13 shared papers)Quan Cheng (10 shared papers)Linhui Wang (22 shared papers)Zaoqu Liu (9 shared papers)Le Qu (19 shared papers)Yifeng Bai (2 shared papers)
In The Last Decade
Aimin Jiang
53 papers receiving 696 citations
Aimin Jiang's Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 156
- Oncology 218
- Immunology 157
- Pulmonary and Respiratory Medicine 218
- Molecular Biology 348
Countries citing papers authored by Aimin Jiang
This map shows the geographic impact of Aimin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimin Jiang more than expected).
Fields of papers citing papers by Aimin Jiang
This network shows the impact of papers produced by Aimin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimin Jiang. The network helps show where Aimin Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimin Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 90 | |
| 2 | CTLs heterogeneity and plasticity: implications for cancer immunotherapy Hit paper breakdown → | 2024 | 62 |
| 3 | 2012 | 48 | |
| 4 | 2022 | 48 | |
| 5 | 2022 | 38 | |
| 6 | 2022 | 38 | |
| 7 | From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy Hit paper breakdown → | 2025 | 34 |
| 8 | 2024 | 30 | |
| 9 | 2021 | 30 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 21 | |
| 12 | 2022 | 20 | |
| 13 | 2020 | 18 | |
| 14 | 2022 | 15 | |
| 15 | 2022 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2024 | 12 | |
| 18 | 2024 | 11 | |
| 19 | 2025 | 10 | |
| 20 | 2024 | 10 |
About Aimin Jiang
Aimin Jiang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Immunology, having authored 63 papers that have together received 709 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (17 papers), Ferroptosis and cancer prognosis (15 papers), Cancer Immunotherapy and Biomarkers (10 papers), Renal and related cancers (8 papers), Epigenetics and DNA Methylation (8 papers), CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (156 citations), Oncology (218 citations), Immunology (157 citations), Pulmonary and Respiratory Medicine (218 citations) and Molecular Biology (348 citations). Aimin Jiang has collaborated with scholars based in China, Hong Kong and Macao. Frequent co-authors include Peng Luo, Anqi Lin, Jian Zhang, Quan Cheng, Linhui Wang, Zaoqu Liu, Le Qu, Yifeng Bai, Xinxin Gan and Anbang Wang. Their work appears in journals such as Frontiers in Immunology, Oxidative Medicine and Cellular Longevity, Advanced Science, Frontiers in Oncology and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.